< %=imgalt%>
US Elections Calendar ~ Pervez Musharraf ~ Iftikhar Muhammad Chaudhry ~ Other International News
Home / International News / Press Releases / September 08, 2008
Emerald Dairy Announces Participation in the Susquehanna Second Annual Beijing Management Summit

Top News

Praja Rajyam membership drive from October 2

Sonia Gandhi says UPA government committed to fighting terrorism

Nepal Maoist Central Committee meet postpone for a month

Arjun Rampal talks about his upcoming flick, EMI

Aditya Birla Group contributes Rs. 5 crores towards flood relief measures in Orissa

Sourav Ganguly decides to retire after Australia series

Girls struggle more than boys to adjust in language-learning environment

The Future of the Internet IDATE's 30Th Annual International Conference 19 & 20 November 2008 - Le Corum, Montpellier (France) Guest Country South Korea

Emerald Dairy Announces Participation in the Susquehanna Second Annual Beijing Management Summit

RESTON, Va., Sept. 8 /Xinhua-PRNewswire-FirstCall/ -- Emerald Dairy, Inc. (OTC Bulletin Board: EMDY), today announced that management will be participating in the Susquehanna Second Annual Beijing Management Summit at the Grand Hyatt Hotel in Beijing. Management will be presenting an overview of the Company at 8 a.m. local time on Friday, September 12th.

Institutional investors who are interested in attending should contact their respective institutional sales representative at Susquehanna.

About Emerald Dairy Inc.:

Through its wholly-owned operating subsidiaries, Emerald Dairy Inc. is a producer and distributor of infant and children's formula, milk powder and soybean products in the People's Republic of China. The Company's products are sold under two brand names -- "Xing An Ling" and "Yi Bai."

Certain statements in this release and other written or oral statements made by or on behalf of the Company are "forward looking statements" within the meaning of the federal securities laws. Statements regarding future events and developments and our future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. The forward looking statements are subject to a number of risks and uncertainties including market acceptance of the Company's services and projects and the Company's continued access to capital and other risks and uncertainties. The actual results the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. These statements are based on our current expectations and speak only as of the date of such statements.

    For more information, please contact:

    In the U.S.:
     Ashley Ammon or Wei-Jung Yang
     ICR, Inc.
     Tel:   +1-203-682-8200

SOURCE Emerald Dairy, Inc.

International News / Press Release source: PR Newswire
Copyright PR Newswire. All Rights Reserved.

International Business News / Press Releases

/C O R R E C T I O N -- China Sky One Medical, Inc./
PR Newswire

Cohen & Steers Funds Quarterly Data Now Available
PR Newswire

Galderma Announces Approval for Differin(R) Gel 0.1% in Japan
PR Newswire

Back-to-Back Top 10 Finishes for Indy Racing League Rookie Mario Moraes
PR Newswire

MutualFirst Announces Increased Second Quarter 2008 Earnings
PR Newswire

Food News / Press Releases

Back-to-Back Top 10 Finishes for Indy Racing League Rookie Mario Moraes
PR Newswire

Morton's The Steakhouse Announces Prime Recipe Contest Winner
PR Newswire

China Kangtai Cactus Biotech Inc. Launches Cactus Cattle Feed and Cactus Fish Feed
PR Newswire

American Lorain Wins Bid to Enter into Two-Year Contract with Yum! Brands
PR Newswire

CMP is Back This Year with Loads of Innovative Ideas and Varieties of Food Ingredients
PR Newswire

International Health News / Press Releases

/C O R R E C T I O N -- China Sky One Medical, Inc./
PR Newswire

Galderma Announces Approval for Differin(R) Gel 0.1% in Japan
PR Newswire

Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU
PR Newswire

Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
PR Newswire

Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock
PR Newswire